Global and China Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Insights, Forecast to 2027

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances.
Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. This report studies the Helicobacter Pylori (H-Pylori) Non-Invasive Testing market, Non-invasive diagnostic tests included stool antigen test, serological, and urea breath test, etc.

Market Analysis and Insights: Global and China Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market
This report focuses on global and China Helicobacter Pylori (H-Pylori) Non-Invasive Testing market.
In 2020, the global Helicobacter Pylori (H-Pylori) Non-Invasive Testing market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Helicobacter Pylori (H-Pylori) Non-Invasive Testing market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Helicobacter Pylori (H-Pylori) Non-Invasive Testing Scope and Market Size
Helicobacter Pylori (H-Pylori) Non-Invasive Testing market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Helicobacter Pylori (H-Pylori) Non-Invasive Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Helicobacter Pylori (H-Pylori) Non-Invasive Testing market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Urea Breath Test
Serology Test
Stool Antigen Test
Others

Segment by Application
Hospitals
Physical Examination Center
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Sekisui Diagnostics
Roche
Danaher
Abbott Laboratories
Medline Industries
Bio-Rad Laboratories
Thermo Fisher Scientific
Quidel
Cardinal Health
Agilent Technologies
Meridian Bioscience
Biomerica
DiaSorin S.p.A
Alpha Laboratories
EKF Diagnostics
Halyard Health, Inc
Coris BioConcept
Certest Biotec SL
Otsuka Pharmaceutical
Savyon Diagnostics
Kibion AB
Boditech Med Inc
Shenzhen Zhonghe Headway Bio-Sci & Tech